What can investors expect from STRM's upcoming Q4 2025 earnings?

**Streamline Health Solutions (STRM) is poised for a challenging Q4 2025 earnings report** based on the following points: 1. **Revenue Decline Expectations**: Investors should anticipate a continuation of the revenue decline trend seen in previous quarters. The consensus estimates for Q4 2025 revenue are not available, but given the downward trend in revenue (e.g., a 22% decrease in revenue from Q2 2024 to Q2 2025), it is likely that the revenue will be lower than Q4 2024's $4.48 million. 2. **Earnings Per Share (EPS) Concerns**: The EPS is expected to be negative, which is consistent with the trend observed in the last few quarters. The exact EPS figure is not available, but given the company's net losses and the lack of positive EPS reports in recent quarters, investors should prepare for a possible worsening of the EPS figure. 3. **Financial Challenges**: Streamline Health Solutions has been navigating financial challenges, including a net loss in Q2 2025 of $2.80 million, which represents a widening loss from the previous quarter. This trend suggests that the company's financial performance may continue to be under pressure. 4. **Strategic Moves**: The company's CEO has recently bought shares in the company, which could be seen as a sign of confidence in the long-term prospects. However, the near-term earnings report is unlikely to reflect this strategic move's impact immediately. In conclusion, while there are some positive signs for the long-term future of Streamline Health Solutions, the upcoming Q4 2025 earnings report is likely to reflect the ongoing financial challenges the company is facing. Investors should expect a difficult quarter with continued revenue declines and negative EPS.